Rapid Micro Biosystems Stock
Rapid Micro Biosystems, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Robert G. Spignesi Jr.
- Employees
- 171
- Market cap
- $35 M
- IPO
- 15/07/2021
Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct…
Rapid Micro Biosystems stock: price history
1D
-9.5%
1W
-14.4%
1M
-31.1%
6M
-66.5%
YTD
-73.6%
1Y
-74.0%
2Y
-12.1%
5Y
-95.5%
10Y
–
Next earnings date
Next earnings date
06/11/2026 (in 20 days)
Volatility around earnings
~42% stronger price swings than usual
Ask the agents about Rapid Micro Biosystems
Analyst assessment of Rapid Micro Biosystems
PRICE TARGET LOW
US$3.00
CONSENSUS
US$5.00
MEDIAN
US$5.00
PRICE TARGET HIGH
US$7.00
0
STRONG BUY
4
BUY
2
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 29/05/2026
Rapid Micro Biosystems stock metrics
P/E
-0.69
P/B
2.02
EV/EBITDA
-0.96
RETURN ON EQUITY
-72.8%
NET MARGIN
-160.5%
DEBT/EQUITY
1.32
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
52.4%
FLOAT SHARES
23,910,559
AVG. DAILY VOLUME (30D)
308,941
Insider transactions (SEC)
Kollender Richard S
Kollender Richard S
Spignesi Robert G. Jr.
WIRTJES SEAN M
Malloy Kirk
Institutional holders
Comparable stocks
Frequently asked questions about Rapid Micro Biosystems stock
What does Rapid Micro Biosystems do?
Rapid Micro Biosystems, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Robert G. Spignesi Jr., the company employs around 171 people.
The IPO was on 15/07/2021; the stock trades on NASDAQ under the ticker RPID.
What do analysts say about Rapid Micro Biosystems stock?
6 analysts rate the stock, the consensus is Buy (as of 29/05/2026).
The average price target is US$5.00, ranging from US$3.00 to US$7.00, with a median of US$5.00.
This is an external assessment, not a statement by Market Jury.
When does Rapid Micro Biosystems report next?
The next earnings date is 06/11/2026.
Around past earnings, price swings were roughly 42% stronger than usual.
Does Rapid Micro Biosystems pay a dividend?
No, Rapid Micro Biosystems currently does not pay a dividend.
Which stocks are comparable to Rapid Micro Biosystems?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Rapid Micro Biosystems stock analyzed?
Clicking "Analyze stock" lets five strategies assess Rapid Micro Biosystems against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.